The Australian Therapeutic Goods Administration (TGA) has granted approval for Arrowhead Pharmaceuticals’ Redemplo (plozasiran), a novel therapeutic agent designed to…
Read More
Molecular Mapping of Bone Marrow Remodeling Reveals Early Inflammatory Drivers of Blood Cancer and Myelodysplastic Syndrome
The human bone marrow is one of the most industrious environments in the human body, a cellular factory that generates…
Read More
Researchers Identify Experimental Strategy to Boost MeCP2 Protein Levels as Potential Therapy for Rett Syndrome
A collaborative research team at the Texas Children’s Duncan Neurological Research Institute (NRI) and Baylor College of Medicine has unveiled…
Read More
